Surgical outcomes of gastro‐entero‐pancreatic neuroendocrine tumors G3 versus neuroendocrine carcinoma-Reference-Cited by-同舟云学术

Surgical outcomes of gastro‐entero‐pancreatic neuroendocrine tumors G3 versus neuroendocrine carcinoma

Published:2022-05-26 Issue:4 Volume:126 Page:689-697
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:Journal of Surgical Oncology

Author:

Li Mu‐Xing¹²,Lopez‐Aguiar Alexandra G.³,Poultsides George⁴,Rocha Flavio⁵,Weber Sharon⁶,Fields Ryan⁷,Idrees Kamran⁸,Cho Cliff⁹,Maithel Shishir K.³^ORCID,Zhang Xu‐Feng¹¹⁰^ORCID,Pawlik Timothy M.¹⁰^ORCID

Affiliation:

1. Department of Hepatobiliary Surgery Institute of Advanced Surgical Technology and Engineering, The First Affiliated Hospital of Xi'an Jiaotong University Xi'an China

2. Department of General Surgery Yan'an Hospital of Traditional Chinese Medicine, Peking University Third Hospital Beijing China

3. Department of Surgery, Division of Surgical Oncology, Winship Cancer Institute Emory University Atlanta Georgia USA

4. Department of Surgery Stanford University Palo Alto California USA

5. Department of Surgery Virginia Mason Medical Center Seattle Washington USA

6. Department of Surgery University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA

7. Department of Surgery Washington University School of Medicine St. Louis Missouri USA

8. Department of Surgery, Division of Surgical Oncology Vanderbilt University Nashville Tennessee USA

9. Department of Surgery, Division of Hepatopancreatobiliary and Advanced Gastrointestinal Surgery University of Michigan Ann Arbor Michigan USA

10. Division of Surgical Oncology The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center Columbus Ohio USA

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.26928

Reference35 articles.

1. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

2. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States

3. Endocrine Tumours: Epidemiology of malignant digestive neuroendocrine tumours

4. Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas

5. Are G3 ENETS neuroendocrine neoplasms heterogeneous?

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low Prognostic Nutritional Index Is Common and Associated with Poor Outcomes following Curative-Intent Resection for Gastro-Entero-Pancreatic Neuroendocrine Tumors;Neuroendocrinology;2023-09-13

2. Chinese Medical Association consensus for standardized diagnosis and treatment of pancreatic neuroendocrine neoplasms;Chinese Medical Journal;2023-09-08

3. Optimal surgical approach for digestive neuroendocrine neoplasia primaries: Oncological benefits versus short and long-term complications;Best Practice & Research Clinical Endocrinology & Metabolism;2023-09

4. A systematic review of therapeutic strategies in gastroenteropancreatic grade 3 neuroendocrine tumors;Therapeutic Advances in Medical Oncology;2023-01